Key result
Current bleeding prediction scores for VTE patients lack adequate validation and do not account for non-vitamin K dependent anticoagulants, highlighting a need for improved risk stratification.
Why the study?
What are the incidence, risk factors, and available prediction scores for anticoagulant-related bleeding in patients with VTE?
What are the incidence, risk factors, and available prediction scores for anticoagulant-related bleeding in patients with VTE?
Current bleeding risk prediction scores for VTE patients lack robust validation and do not account for newer non-vitamin K dependent anticoagulants, highlighting a need for improved risk stratification tools.
No takes yet. Share an insight, caveat, or question.
Existing scores may not reliably predict bleeding with NOACs; leaves open need for updated, validated tools in prospective studies.
Klok et al. (2014) conducted a review in Venous thromboembolism (VTE). Anticoagulants was evaluated. Current bleeding prediction scores for VTE patients lack adequate validation and do not account for non-vitamin K dependent anticoagulants, highlighting a need for improved risk stratification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: